Katie Whitehead, Ph.D. Associate Professor, Carnegie Mellon University, Duncan & Suzanne Mellichamp Emerging Leader Lecture, From Farm to Pharmacy: A Strawberry-Derived Solution to Oral Protein Delivery
Seminar (In-Person + Zoom)
This BIOE 225 Seminar will be hosted in person as well as online via Zoom. RSVP to receive the zoom link by emailing info@bioengineering.ucsb.edu.
Zoom will open after the host has joined at the start of each seminar. You can ask questions through the chat forum and by raising your "hand" and the speaker will call on you.
Speaker:
Katie Whitehead, Ph.D.
Associate Professor
Department of Chemical & Biomedical Engineering
Carnegie Mellon University
Faculty Host
TBA
Duncan & Suzanne Mellichamp Emerging Leader Lecture
From Farm to Pharmacy: A Strawberry-Derived Solution to Oral Protein Delivery
Abstract:
Oral delivery is the most patient-friendly mode of drug administration. Unfortunately, it is not possible for protein and other macromolecular drugs because the gastrointestinal tract is not permeable to undigested large molecules. Although many chemical permeation enhancers have been identified that improve the intestinal absorption of biologics, they often cause cytotoxicity or damage the intestinal mucosa. To address this issue, we sought to identify a permeation enhancer derived from fruits and vegetables, hypothesizing that the compounds found in natural foods would be well-tolerated by the gastrointestinal tract. Following a screen of over 100 fruits, vegetables, herbs, and fungi, we identified strawberry as a potent enhancer of macromolecular permeability both in vitro and in vivo. Natural product chemistry techniques revealed pelargonidin, an anthocyanidin, as the active compound in strawberry. In mice, pelargonidin enabled 100% bioactivity of oral insulin relative to the current gold standard of subcutaneous injection, without causing toxicity following 30 days of daily treatment. These results underscore the potential of naturally derived compounds in biomedical applications and demonstrate pelargonidin as an especially potent new enhancer for the oral delivery of biologics.
Bio:
Kathryn A. Whitehead is a Professor in the Departments of Chemical Engineering and Biomedical Engineering (courtesy) at Carnegie Mellon University. Her lab develops drug delivery systems for RNA, proteins, and applications in maternal and infant health. She obtained bachelor and doctoral degrees in chemical engineering (Univ. of Delaware; Univ. of California, Santa Barbara) before an NIH Postdoctoral Fellowship at MIT. Prof. Whitehead is the recipient of numerous awards, including the NIH Director’s New Innovator Award, the DARPA Director’s Fellowship, and the ASEE Curtis W. McGraw Research Award. She has also received the Controlled Release Society’s Young Investigator Award and served on its Board of Directors. Prof. Whitehead is an elected Fellow of the American Institute for Medical and Biological Engineering and the Controlled Release Society. In 2021, she gave a TED talk on the lipid nanoparticles (i.e., “fat balls”) used in the in the COVID-19 mRNA vaccines. Her publications have been cited over 9,000 times, and her patents have been licensed and sublicensed for reagent and therapeutic use.
